Pascal Biosciences Inc ( (TSE:NEVI) ) has shared an update.
Nevis Brands Inc reported a significant increase in revenue for fiscal year 2024, reaching $1.55 million compared to $671,545 in 2023, while also reducing its net loss. The company successfully expanded into new markets and launched new products, maintaining a strong market position in Washington and Missouri. Despite a challenging fourth quarter due to market dynamics in several states, Nevis remains optimistic about future growth, particularly with its Hemp Derived THC beverages and a low capital expenditure model focused on licensing and operational cash flows.
More about Pascal Biosciences Inc
Nevis Brands Inc is a leading provider of cannabis beverage brands, innovating and developing products consumed by millions across 11 states in the U.S. The company is known for its Hemp Derived THC beverages and licenses its products to enhance offerings by cannabis product manufacturers and distributors. Nevis is publicly traded on the CSE under the symbol ‘NEVI’.
YTD Price Performance: -40.0%
Average Trading Volume: 21,843
Technical Sentiment Signal: Buy
Current Market Cap: C$2.3M
For a thorough assessment of NEVI stock, go to TipRanks’ Stock Analysis page.